Stereotaxis, Inc. (STXS) stock
STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.88+0.08 (+9.89%)
Close on Nov 17, 2026Market cap $88.39MP/E –Yield –
Stereotaxis enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Stereotaxis's enterprise value was $76.58M on Nov 11, 2026, against $207.56M a year earlier. Over the last 5 years it ranged from $72.96M to $426.92M, with a median of $148.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $76.58M | -60.4% |
| 2025 | Dec 31, 2025 | $193.38M | +6.7% |
| 2024 | Dec 31, 2024 | $181.20M | +55.8% |
| 2023 | Dec 29, 2023 | $116.29M | -7.9% |
| 2022 | Dec 30, 2022 | $126.24M | -70.4% |
| 2021 | Dec 31, 2021 | $426.92M | +33.4% |
| 2020 | Dec 31, 2020 | $319.93M | +10.6% |
| 2019 | Dec 31, 2019 | $289.28M | +716.8% |
| 2018 | Dec 31, 2018 | $35.42M | +163.6% |
| 2017 | Dec 29, 2017 | $13.44M | +176.3% |
| 2016 | Dec 30, 2016 | $4.86M | -83.8% |
| 2015 | Dec 31, 2015 | $30.09M | -21.1% |
| 2014 | Dec 31, 2014 | $38.15M | -46.1% |
| 2013 | Dec 31, 2013 | $70.75M | +73.1% |
| 2012 | Dec 31, 2012 | $40.88M | – |
See a number that looks wrong?